Recently, the PUMCH Summit Forum on Translational Medicine of Hepatobiliary Malignancies was held co-sponsored by the Department of Liver Surgery of Peking Union Medical College Hospital (PUMCH), the Hepatobiliary Microcirculation Branch of the Chinese Society of Microcirculation, the Hepatobiliary Branch and the Youth Committee of Physicians Section of Western Returned Scholars Association and the Beijing Cancer Prevention and Treatment Research Association. Du Bin, vice president of PUMCH, attended the meeting.

In the academic exchange session, Zhao Haitao introduced a cohort study conducted by the Department of Liver Surgery of PUMCH. Nine cases of advanced liver cancer (stage IIIB) with extrahepatic metastasis were enrolled in this study. After translational therapy, these patients were successfully degraded and gained chance of surgery with post-surgery long-term tumor-free survival. This study has become one of the evidences of the newly published "Chinese Expert Consensus on the Treatment of Liver Cancer Translational Therapy (2021 Edition)". The relevant article was accepted by the Journal of Hepatobiliary Surgery and Nutrition, and the report received remarkable response.

Through the release of consensus, academic reports, keynote speeches, special discussions and etc., a comprehensive interpretation of the frontier developments in the field of liver and gallbladder at home and abroad has broadened the vision of the participants and will also benefit more patients.

Group photo of experts and participants of the forum

Text: Department of Liver Surgery

Photo: Department of Liver Surgery

Translator: Xu Haifeng

Editor: Xu Xiaohan